Literature DB >> 6300336

Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.

S P Sivam, J C Norris, D K Lim, B Hoskins, I K Ho.   

Abstract

The effects of acute and chronic administration of diisopropylfluorophosphate (DFP) to rats on acetylcholinesterase (AChE) activity (in striatum, medulla, diencephalon, cortex, and medulla) and muscarinic, dopamine (DA), and gamma-aminobutyric acid (GABA) receptor characteristics (in striatum) were investigated. After a single injection of (acute exposure to) DFP, striatal region was found to have the highest degree of AChE inhibition. After daily DFP injections (chronic treatment), all brain regions had the same degree of AChE inhibition, which remained at a steady level despite the regression of the DFP-induced cholinergic overactivity. Acute administration of DFP increased the number of DA and GABA receptors without affecting the muscarinic receptor characteristics. Whereas chronic administration of DFP for either 4 or 14 days reduced the number of muscarinic sites without affecting their affinity, the DFP treatment caused increase in the number of DA and GABA receptors only after 14 days of treatment; however, the increase was considerably lower than that observed after the acute treatment. The in vitro addition of DFP to striatal membranes did not affect DA, GABA, or muscarinic receptors. The results indicate an involvement of GABAergic and dopaminergic systems in the actions of DFP. It is suggested that the GABAergic and dopaminergic involvement may be a part of a compensatory inhibitory process to counteract the excessive cholinergic activity produced by DFP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300336     DOI: 10.1111/j.1471-4159.1983.tb13584.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: II. Dopamine receptors.

Authors:  D K Lim; Z J Yu; B Hoskins; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

2.  Early differential induction of C-jun in the central nervous system of hens treated with diisopropylphosphorofluoridate (DFP).

Authors:  T V Damodaran; A A Rahman; M B Abou-Donia
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

3.  Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.

Authors:  H Soininen; L Unni; S Shillcutt
Journal:  Neurochem Res       Date:  1990-12       Impact factor: 3.996

4.  Effect of acute and chronic diisopropylfluorophosphate and atropine administration on somatostatin binding in the rat frontoparietal cortex and hippocampus.

Authors:  I A Alonso; J C Prieto; E Arilla
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Brain neuronal chromatin responses in acute soman intoxicated rats.

Authors:  L J Martin; J A Doebler; T J Wall; T M Shih; A Anthony
Journal:  Neurochem Res       Date:  1986-08       Impact factor: 3.996

6.  Action of an irreversible acetylcholine esterase inhibitor, soman, on muscarinic hyperpolarization in cat bladder parasympathetic ganglia.

Authors:  E Kumamoto; P Shinnick-Gallagher
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

7.  Repeated exposure to diisopropylfluorophosphate (DFP) produces increased sensitivity to cholinergic antagonists in discrimination retention and reversal.

Authors:  K Raffaele; D Olton; Z Annau
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection.

Authors:  Teresa Mann; Karl Zilles; Felix Klawitter; Markus Cremer; Alexander Hawlitschka; Nicola Palomero-Gallagher; Oliver Schmitt; Andreas Wree
Journal:  Front Neuroanat       Date:  2018-08-10       Impact factor: 3.856

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.